Total synthesis reveals antibacterial activity of protulactone B against Gram-negative pathogens, indicating potential for novel antimicrobial agents.
A total synthesis of the structurally unique fungal metabolite (-)-protulactone B is reported. The convergent strategy is based on methyl α-l-rhamnopyranoside as a chiral pool starting material. A novel method for the stereoselective inversion of the C3 configuration of the rhamnoside precursor was developed, proceeding through a cyclic carbonate intermediate. Furthermore, an unprecedented, one-pot transformation mediated by dibutyltin oxide was discovered, enabling chemoselective cleavage of a cyclic carbonate with concurrent formation of a six-membered δ-lactone. This efficient sequence (8 longest linear steps, 20.2% overall yield) provided ample material for biological evaluation. The synthetic (-)-protulactone B exhibited selective antimicrobial activity against specific Gram-negative pathogens, a profile distinct from its inactive congener protulactone A. This work provides a practical synthetic route and novel methodologies that will facilitate further study of this natural product family.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: